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ABSTRACT 
The methodological implications of a differential psychopharmacology 
are discussed. It is shown that the technique of stratifying subjects 
with personality scores depends on one basic assumption: the personali-
ty score is not affected by the other experimental factors. Two experi-
ments are reported in which pre- and posttest (after the experiment) 
scores were measured. The pre-post-differences showed themselves to be 
affected by the medication. It is argued that in psychopharmacological 
experimentation an additional step must be included. All non-treatment 
factors must be examined for their stability in the course of the 
experiment. If they are stable, usual evaluation may take place. If 
changes are attributable to the treatment, personality scores must be 
regarded as dependent variables. They have to be evaluated together 
with the other observables with a multivariate model. Additionally, a 
procedure like this yields as "experimental differential psychology" 
a self-reliant contribution to the problems of differential psychology. 
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I. THE PATTERN OF EXPERIMENTATION IN PSYCHOPHARMACOLOGY 
The general pattern of experimenting in psychopharmacology is given by 
the expression 
R = f (O,S) 
where R = reaction, D = drug and S = situation. The effect in R is 
interpreted as a consequence of the factors D and S, given by 
independent definition in physical (e.g. db white noise) and chemical 
(e.g. 5 mg from a benzo-diazepine) terms. The differential approach 
in psychopharmacology (as introduced by Eysenck, in Germany by Lienert 
and Janke) is comparable with the evolution from behaviorism to neb-
behaviorism. A "cognitive" element named personality is inserted in 
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the formular above: 
R = f (D,S,P) 
with P = personality. This pattern is also instructive for the way in 
which experiments are conducted. Since D,S, and P as factors can be 
varied independently, experiments in psychopharmacology are regularly 
multifactorial. Our further considerations will emphasize above all the 
consequences of this model for the experimental design. 
In psychopharmacology a large number of results extended the influence 
of the two independent factors personality and situation. First these 
factors were thought to be only modifying the drug response, but more 
and more a constitutive function was noted. 
In a systematic overview, Janke and Debus demonstrated (Debus and Janke, 
1978; Janke and others, 1979) the essential effects of situation and 
personality on drug response. Following these authors, the present 
state of an individual is influenced by the drug, by the situation and 
by long-term characteristics, more generally by personality. The present 
state is modified by these factors, resulting in a primary drug response , 
covert to the experimenter. This primary response is the equivalent to 
the neo-behavioristic internal response, which in interaction with the 
possibilities to react in the experimental situation yields the overt, 
observable response named here "secondary drug response". 
The advantage of such a model is obvious: most of the experimental 
results can be ordered. But it is obvious too that the high generality 
hides some problems: 
- There is no attempt to make understandable the interaction between 
personality and situation. 
The personality factor is an experimental tool to control the'psycho-
logical situation' of the subjects, ending in a reduction of variance. 
The experimenter states the hypothesis that the organismic factor is 
a generalized reaction to situations of which the experimental situa-
tion is part. The personality factor yields groups of subjects with 
comparable reactions (given the validity of the trait for the actual 
state). Introduction of a personality variable is in fact a declaration 
by the experimenter that the same situation describable in objective 
terms is psychologically not the same for all sUbjects. We have had 
an extended discussion in personality theory about the model of person-
situation interaction. The controversy is still going on, recently 
with Eysenck & Eysenck's (1980) rejection of the arguments from 
Mischel (1968). But without respect to the ending of this discussion 
one fact still remains: the results of personality research do not 
allow to speak of situation and personality as independent factors. In 
the experimental procedure the factors personality and situation may 
be varied independently. Extraversion and a noise condition are inde-
pendent in an experimental and statistical view. But psychologically' 
they are highly dependent: a zero correlation between personality and 
situation would render personality theory superfluous. 
- There is no attempt to make understandable the interaction between 
drug and situation. 
Do subjects treated with a tranquillizing drug experience a situation 
in the same way as subjects with placebo? Since the work of Lewin it 
is accepted that situation is the 'state of the actual field' which 
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must be defined in psychological terms. Objective descriptions may only 
be an approximation to the description of the psychological situation. 
-There is also no attempt to make understandable the interaction between 
personality and drug. 
Are the reactions to drugs different for subjects with different person-
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the long-term characteristic (personality trait) itself or the portion 
of short-term characteristics (state) in the personality concept? Anew 
these factors are independent: each drug condition may be applied to 
each personality condition in stochastic manner. Thus, the conditions 
for the internal validity of the experiment sensu Campbell andStanley, 
(1963) is guaranteed. But the problems are essentially the same as in 
the case of situational variables. 
11. A PRAGMATIC VIEW ON PERSONALITY VARIABLES 
As this discussion shows, the role of the personality variables is con-
stitutive and may be discussed in highly theoretical terms. But we also 
can look at them from a pragmatic view point. There was a practical 
need to introduce such modifying variables because drug effects have 
been often too small. It is a usual tool in experimentation to reduce 
intra-group variance by stratifying the subjects. 
Let us start with a single-situation experiment with drug as the only 
treatment factor. V(T) is the effect variance due to the drug, V(E) 
the error variance. By introducing an organismic factor (Edwards, 
1968) like personality, V(E) is split into V(E) = V(p) + V(PxT) + 
V(E*) where V(P) is variance due to personality, V(PxT) is the inter-
action between drug and personality and V(E*) is the new (smaller) 
error variance. If the sum V(P) + V(PxT) is small or, equivalently, 
V(E) is of comparable size as V(E*) there would be no need for or-
ganismic factors. A 'differential psychopharmacology' would not have 
been created. This research is essentially based on the interaction 
term V(PxT) with V(T) small or zero. 
If an effect in V(P) is observed without an effect on V(PxT), then the 
experimenter has chosen an organismic factor which is correlated with 
the dependent variable (observable) or, in another view, we have de-
fined two or more subpopulations. The conditions to detect treatment 
effects are better now - some variance in the observable is assigned 
to organismic differences independent from drug action. 
In single-situation experiments significant effects on V(P) and/or 
V(PxT) may be considered as an internal validation of the organismic 
factor personality. If an anxiolytic drug is given to a sample of 
subjects stratified to anxiety and the dependent variable is 'expe-
rienced anxiety' we should expect an effect on the organismic factor, 
whether as main or interaction term. If not, the validity of the 
organismic trait for the actual state in the experimental situation 
is questionnable. A 'hidden effect' of the personality factor has to 
be seen in the technique of many experimenters to improve drug effects 
only in subpopulations (subjects with high neuroticism, high anxiety 
and so on). This technique may be effective in some cases but has a 
great disadvantage: the validity of the personality variable is only 
based on plausability, but is not proved explicitly in the experimental 
situation. If variation of the organismic factor is seen as 'treatment 
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by the nature', the definition of subpopulations is comparable to drug 
studies without reference drugs or without placebo. It is impossible 
to explain treatment effects as general or as differential only, 
because V(T) and V(PxT) are confounded. 
In the second case V (PxT) is significant. If additionally V(P) becomes 
significant, the organismic factor has led to a differential experience 
of the experimental situation which is modified by the drug (e.g., 
subjects with high anxiety show a greater decrease in experienced anx-
iety than subjects with low anxiety). On the other side, when V(P) is 
not significant, the organismic factor is drug-specific, not situation-
specific. Figure 1 shows the possible results. 
OBSERVABLE OBSERVABLE 
TREAT 1 TREAT 2 TREAT 1 TREAT 2 
A. B. 
Fig. 1. Types of interactions between personality 
variables and drug treatment. 
In case A (left side of Fig. 1) the personality factor differentiates 
between the persons without respect to treatment (main effect). The 
personality factor describes the differential experience of the experi-
mental situation. Drug modifies this experience. In case B (right side 
of Fig. 1) the experimental situation is the same for the two sub-
populations given by the organismic factor (no main effect personality) 
which itself shows as situation-indifferent. But reaction to the drug 
treatment is clearly dependent on personality. 
So, introducing an organismic factor in psychopharmacological experi-
ments we have to decide whether this factor is determining 
a. the experience of the situation (a case only interesting in 
differential psychology), 
b. the experience of the drug or 
c. the reaction to situation and drug. 
Case B as a double disordin~l interaction (see Bredenkamp, 1980) would 
be highly desirable. The reaction to drug would be determined by char-
acters of subjects which are independent from situation. Perhaps exampleE 
may be found in 'physiological traits' - psychology has not been able 
to produce situation-free parameters up to now. Even the purest 
'personalist' would not declare that situation should be neglected. 
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So at the moment one should expect only effects of personality on situ-
ation and drug simultaneously. The overview about the effects of the 
organismic factors 'extraversion' and 'action-orientation' given by 
Janke and others (1979) reveals in fact that with few exceptions only 
interactions of our type A are occuring in psychopharmacological re-
search. This indicates that organismic factors change situation as 
well as drug response. 
Interpretation of those interactions is difficult and dependent on the 
psychophysiological model of the researcher. But before arguing with 
theoretical terms, a reconsideration of the methodological implications 
which are underlying the experimental procedure has to take place. 
Ill. THE TECHNIQUE OF STRATIFYING 
As mentioned stratifying is a tool to reduce error variance. Usually 
in statistical textbooks only one desiderat is stated: the stratum 
variable must be independent from the observable. That is why in experi-
mental practice the stratum variable is measured previous to the experi-
mental action. The independence of the stratum variable is only a 
question of measurement, not one of the association between stratum 
variable and observable. If in a teaching experiment comparing two 
methods of learning, intelligence is introduced as stratum variable, 
results in performance are highly dependent on this factor (the ob-
servable is correlated with the stratum variable). Only error variance 
is reduced. 
But independence in measurement of both variables is only a necessary, 
but not sufficient condition in designs with stratum variables. The 
logic of factorial designs (usually evaluated with ANOVA) demands that 
effects of factors are orthogonal for all cells in two and higher orders. 
In nonpsychological experiments this demand is usually out of question. 
Suppose a pharmacologist is interested in the interaction of a certain 
drug with alcohol. He designs an experiment with two levels of dosages 
of drug and alcohol. By injecting the drugs in animals he can be sure 
that at every level of drug every dosage of alcohol is the same. Or: 
if the observable in this experiment would be 'dosage of alcohol' only 
a main effect alcohol has to be expected, no other effect is possible. 
Every main effect of this observable on other factors, every inter-
action with other factors would render the results uninterpretable, 
because treatment is no longer guaranteed to be successful. 
The desiderat of independence seems trivial in experimenting with 
treatment factors, though becomes critical in designs with stratifying 
factors. Eysenck's model of the effects of stimulant action (excitation -
introversion) and depressant action (inhibition - extraversion) may 
be a very dangerous one if you read it in the reverse direction. Then 
it may be possible that drugs change personality or: personality be-
comes drug specific. But if the personality factor (thought as in-
dependent factor) changes itself during the experimental action,the 
effects are no longer interpretable. Following these considerations, 
a precondition for interpretation is the stability of the organismic 
factor in the course of the experiment. But we have great empirical 
evidence that personality variables are affected by drugs. 
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IV. EMPIRICAL EXAMPLES 
In an experiment from Kohnen & Krliger (1981) N=72 healthy young subjects 
(36 males and females) were divided by random in 3 groups receiving 
placebo, 2.5 and 5.0 mg of the benzodiazepine lopirazepam. In the course 
of the experiment (2 hours after the oral application of the drug) they 
had to solve arithmetic tasks sitting in a circle with 6 members and 
being called up by the experimenter one by one. They had to stand up 
and to calculate for 1 minute. This call-up situation was shown to be 
highly stressing to the subjects (see Kohnen and Lienert, 1980). Days 
before the experiment subjects got the FPI (Fahrenberg and others, 1973) 
as a personality test which among other scales also measures neuroticism. 
Scores were thought to stratify subjects. After the experiment (4 hours 
after application and 1 hour after the stressing experienc~ in the 
group) subjects got the parallel form of the test. The difference 
between the pretest and posttest score of neuroticism (N2 - N1) was 
calculated and introduced in the ANOVA as observable with drug treat-
ment as independent factor. 
Following our considerations above drug effects in connection with 
personality factors can only be interpreted if drug does not change 
personality in the course of the experiment. Thus we expected that the 
null hypothesis of no difference in the pre-post values is not to be re-
jected. 
With F = 3.12 (df 2,69) in the unifactorial ANOVA HO has a probability 
smaller than 5%. Changes in neuroticism scores are attributable to drug 
levels. This effect is not due to the initial . values (the pretest 
scores). In the respective ANOVAs we got 
a. for the pretest score an F-value of 2.62 (df 2,69), 
b. for the posttest score an F = 0.60 (df 2,69). 
Both F-values are not significant, a result which supports trait theo-
rists. Also the retest correlations are sufficient: for the placebo 
group r(tt) = .25, for 2.5 mg r(tt) = .86 and for 5.0 mg r(tt) = .84 
with n = 24 in each group. With exception of the placebo group coef-
ficients are of expected size. Only the calculation of the difference 
N2-N1 disturbs the picture. In Fig. 2 A (upper left) the changes N2-N1 
are plotted against medication separated for the subjects with high 
and low neuroticism pretest score. 
The differentiation according to the pretest score (N+,N-) shows that 
shift in the neuroticism score is,except to the placebo/N- group, 
generally: the posttest scores are the more stable the higher the 
dosage. An interpretation may be that highly threatening situations 
(as the call up situation is) lead to a repression of anxiety which is 
extremely shown by high neurotics in the placebo condition, not by the 
subjects with low neuroticism. If the anxiolytic action of the drug is 
the liberation of anxiety (as Lader, 1978, suggests) the tranquillizing 
agent enables the subjects to 'handle' the situation in its challenging 
aspects. The result can be a stabilization of reported neuroticism. 
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Fig. 2. Pre-posttest-differences of neuroticism 
dependent from medication in two experiments, 
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This psychopharmacological interpretation is not substantial for our 
considerations - other models are possible. Essential is the fact that 
the stratifying factor personality itself changes in the course of the 
experiment dependent from the treatment factor. In the language of 
differential psychology this result indicates a greater part of state 
aspects in the neuroticism score. The methodological implications will 
be discussed below after we have reported another experiment with 
comparable results. 
In an experimental analog to a group-psychotherapy situation Krliger and 
Kohnen (1981) realized a wide variety of social situations. The program 
tried to generate very different situations in groups of 6 persons 
(3 male, 3 female) as discussions between two or more, but also exer-
cises with touching the others. Phases of medication and self-reflectior 
are also integrated following the lines of the Gestalt-therapy from 
Perls (1976). In total a more relaxed situation was created with some 
stressful events (like touching). As tranquillizing agent the benzo-
diazepine prazepam in the dosages of 10 and 20 mg was used together 
with placebo. Four groups of subjects (total N = 24) got previous to 
the experiment the FPI (yielding the pretest neuroticism score). Four 
hours after medication and 1 hour after the group dynamics subjects 
were measured with the parallel scale (posttest score). The results 
are shown in Fig. 2 B (left below) separated for subjects with high (N+: 
and low (N-) neuroticism pretest score. 
In total the posttest score is lower than the pretest score for all 
groups. The results are inverse to those reported above: the higher 
the dosage the lower the posttest score. The retest-coefficients are 
for the placebo group .55, for the 10 mg group .41 and for the 
20 mg group .10 (n = 8). The interpretation of the drug effect would 
be comparable to those given above. The therapeutic effect of group 
dynamics is greater in the verum groups which, as in the experiment 
above, are better able to 'handle' the situation, here in its relaxing 
aspects. 
The effect is with F = 1.89 (df 2,21) not significant (p = 17.5%) in 
the ANOVA. Essentially for our purposes is another fact. N = 15 
subjects of this experiment are the same as in the call up experiment 
reported above. The two experiments were separated by two months. Now 
we can ask whether the inverse effects of the two total groups (N = 72 
and N = 24) are replicated in the subgroup (N = 15) involved in both 
experiments. Results are shown in Fig. 2 C (right above) and Fig. 2 D 
(left below). As may be seen the course of the total group is fully 
replicated by the subgroup. The same persons show in one situation an 
increasing, in the other situation a decreasing course of difference 
scores. 
V. DISCUSSION 
The retest-correlations showed that a constant character was measured. 
The changes in scores attributable to the situation and medication 
indicate that self-description varies if the psychological situation 
is changed. The psychological situation is influenced by the characters 
of the situation (threatening call up, more relaxing group dynamics) 
as well as by the drug. This result gives great hope that psychopharma-
cology may be used as an 'experimental differential psychology'. But 
these results also show a great problem for the methodology of a 
'differential psychopharmacology'. 
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The organismic factor neuroticism was thought to be independent in a 
statistical manner since it was measured before the experiment. Results 
show that treatment changes this score. The psychological interpretation 
is simple: neuroticism has to be seen as a combination of a trait and 
a state variable. The trait-aspect is measured in the high retest-
correlation, the state-aspect in the treatment effect. It is another 
question to think that treatment has changed the trait. Subjects were 
healthy young people, treatment was a single application - a greater 
change in the trait cannot be expected. This problem is more one of 
differential psychology but has no consequence in our discussion of the 
methodological implications of a stratum variable affected by medication. 
Statistically th~ results indicate that the formal model of ANOVA is 
violated. Effects of the factors themselves have to be the same for 
every group in the experimental design. If we have had as observable 
'mg tranquillizer in blood' and ANOVA would have shown that the mgs 
are different for subjects with high and low neuroticism, nobody would 
interprete the effects on all observables introduced, arguing that 
medication conditions were different. The same consideration for neu-
roticism yields difficulties in the interpretation. 
What consequences should be drawn? In a substantial sen~our results 
render the concept of neuroticism not questionnable. They emphasize 
only the necessity for a reconsideration about what portions of this 
concept are to be seen as trait and state. To what extent is neuro-
ticism a measure of the actual state of the organism? What is rendered 
questionnable is the method of evaluating experimental designs includ-
ing stratifying variables by the model of the 'uni-observable' ANOVA 
(to use a distinction of Lienert & Krauth, 1974) with the stratum 
variable as factor. If stratum variables can be shown as affected by 
treatment factors the logic of ANOVA is violated. Interpretation of 
main and interaction effects is no longer conclusive. 
On the other hand, those stratifying variables could be shown as 
highly effective in psychopharmacology. There are only two ways out of 
the problematic methodological situation: 
1. If stratum variables are affected by treatment they are in fact 
observables. If dependence of pharmacological effects from those 
variables is given, a multivariate ('multi-observable') evaluation 
has to take place. Drug effects are not to be proved with the model 
of two factors and one observable (factors drug x personality 
affect o.bservable) but with the model of one factor and two observ-
abIes (factor drug affects the observables personality x observable). 
Thus differential psychopharmacology becomes necessarily multivariate. 
2. Controlling stratum variables has to be done not by introducing them 
as factors in the ANOVA but by defining two ore more subpopulations 
with the stratum. Subjects with high or low neuroticism are no long-
er viewed as coming from the same population. Doing so, in the ANOVA 
no common variance can be defined for stratified groups. The way 
out is to evaluate the drug effects separately for the subpopulations. 
The two-factorial design recurs to two one-dimensional designs. This 
procedure is suggested as the most conclusive by Lienert (1981). 
Basic requirement for both ways is information about the effect of 
treatment on the stratum variable. This information can only be gotten 
with additional experiments. All independent variables in an experiment 
which not can be randomized (non-treatment factors) have to be 
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remeasured in the course of the experiment. The first analysis has to 
prove whether the difference between pre- and posttest score has an 
effect on the treatment-factor or not. Only in the latter case, can 
statistical analysis be made as usual. 
An effect occuring, evaluation becomes complicated: the stratum 
variable has to be considered as a covariate. It has to be decided 
whether (a) the pretest stratum score, (b) the posttest score, 
(c) the difference pre-post, or (d) the sum pre + post is the adequate 
measure to be introduced in the (now) multivariate evaluation. 
A procedure like this has to wait for the end of the experiment before 
knowing what has been the independent factors in the experiment. This 
is unsatisfying for psychology (and in a strong sense not allowed by 
the statistical model). Therefore we want to argue for a multivariate 
model which enables the experimenter to plan experiment and evaluation 
of data fully in advance. Since it is not clear up to now how great the 
portions of situation, of state, of trait are in our personality con-
cepts we should be conservative in evaluating those effects by consider-
ing them as observables. This is no disadvantage for differential 
psychology: a deeper knowledge about the effect of treatment on person-
ality scores is in fact experimental differential psychology. Thus 
differential psychopharmacology with personality as a dependent variable 
yields a self-reliant contribution to differential psychology 
(Krliger, 1981). 
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